Back to search

Article

Term Infant Formula Supplemented with Human Milk Oligosaccharides (2′Fucosyllactose and Lacto‐N‐ neo tetraose) Shifts Stool Microbiota and Metabolic Signatures Closer to that of Breastfed Infants

2016-04-01

Abstract excerpt

Human milk oligosaccharides (HMOs) may provide benefits to formula‐fed infants in part by influencing the establishment of the intestinal microbiota. We evaluated effects of infant formula with 2 HMOs (2′Fucosyllactose [2′FL] and Lacto‐N‐ neo tetraose [LNnT]) on the early intestinal microbiota in infants (ClinicalTrials.gov NCT01715246). Healthy term infants ages 0–14 days were randomly assigned to intact protein...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4dd0eb5f-75e8-5e5f-8cae-2ba3f35f63e1
DOI
10.1096/fasebj.30.1_supplement.275.7
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Term Infant Formula Supplemented with Human Milk Oligosaccharides (2′Fucosyllactose and Lacto‐N‐ neo tetraose) Shifts Stool Microbiota and Metabolic Signatures Closer to that of Breastfed InfantsDOI 10.1096/fasebj.30.1_supplement.275.7
Select a neighboring publication to make it the new centre.